Cellerant Therapeutics, Inc.
Edit Page
Report
Scan day: 17 February 2014 UTC
11
Virus safety - good
Description: Products based on the regulation of the human haematopoietic (blood-forming) system.
Cellerant Therapeutics is a clinical stage biotechnology company focused on the regulation of the hematopoietic (blood-forming) system. The Company is developing human stem cell and antibody therapies for oncology applications and blood-related disorders. Cellerant's lead product, CLT-008 is currently in two Phase 1 clinical trials in patients with hematological malignancies. The Company also has a Cancer Stem Cell (CSC) antibody discovery program focused on therapies for acute myeloid leukemia, multiple myeloma and myelodysplastic syndrome.
Size: 552 chars
Contact Information
Email: —
Phone&Fax: —
Address: —
Extended: —
WEBSITE Info
| Page title: | Cellerant Therapeutics |
| Keywords: | |
| Description: | |
| IP-address: | 168.143.48.42 |
WHOIS Info
| NS | Name Server: NS51.DOMAINCONTROL.COM Name Server: NS52.DOMAINCONTROL.COM |
| WHOIS | Status: clientDeleteProhibited Status: clientRenewProhibited Status: clientTransferProhibited Status: clientUpdateProhibited |
| Date | Creation Date: 15-may-2002 Expiration Date: 15-may-2014 |